TODESCHINI, Paola
 Distribuzione geografica
Continente #
NA - Nord America 2.808
EU - Europa 1.132
AS - Asia 1.093
SA - Sud America 173
Continente sconosciuto - Info sul continente non disponibili 78
AF - Africa 22
OC - Oceania 6
AN - Antartide 1
Totale 5.313
Nazione #
US - Stati Uniti d'America 2.727
CN - Cina 363
PL - Polonia 359
SG - Singapore 332
IT - Italia 157
UA - Ucraina 151
BR - Brasile 141
DE - Germania 139
HK - Hong Kong 130
FI - Finlandia 91
VN - Vietnam 85
GB - Regno Unito 65
TR - Turchia 44
CA - Canada 41
FR - Francia 39
IN - India 29
RU - Federazione Russa 29
IE - Irlanda 28
BD - Bangladesh 21
IQ - Iraq 17
ID - Indonesia 15
SE - Svezia 14
MX - Messico 12
NL - Olanda 11
ES - Italia 10
AR - Argentina 9
ZA - Sudafrica 9
JP - Giappone 8
LT - Lituania 8
EC - Ecuador 7
TW - Taiwan 6
BE - Belgio 5
CZ - Repubblica Ceca 5
JM - Giamaica 5
KR - Corea 5
SA - Arabia Saudita 5
AU - Australia 4
CO - Colombia 4
CR - Costa Rica 4
MY - Malesia 4
PK - Pakistan 4
SV - El Salvador 4
AE - Emirati Arabi Uniti 3
AT - Austria 3
BG - Bulgaria 3
CL - Cile 3
GP - Guadalupe 3
GT - Guatemala 3
KG - Kirghizistan 3
KZ - Kazakistan 3
LU - Lussemburgo 3
MA - Marocco 3
NG - Nigeria 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
UZ - Uzbekistan 3
VE - Venezuela 3
AL - Albania 2
BY - Bielorussia 2
CH - Svizzera 2
EU - Europa 2
IR - Iran 2
LK - Sri Lanka 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
AO - Angola 1
AQ - Antartide 1
AZ - Azerbaigian 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BZ - Belize 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
GE - Georgia 1
GY - Guiana 1
HN - Honduras 1
IL - Israele 1
JO - Giordania 1
LC - Santa Lucia 1
LV - Lettonia 1
LY - Libia 1
MU - Mauritius 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PR - Porto Rico 1
PT - Portogallo 1
RO - Romania 1
TH - Thailandia 1
TO - Tonga 1
Totale 5.237
Città #
Warsaw 359
Ashburn 283
Fairfield 248
Singapore 199
Woodbridge 178
San Jose 139
Houston 128
Seattle 119
Hong Kong 111
Jacksonville 102
Ann Arbor 99
Chandler 94
New York 93
Cambridge 87
Wilmington 86
Beijing 76
Los Angeles 61
Helsinki 60
Council Bluffs 59
Dearborn 59
The Dalles 58
Princeton 48
Brescia 36
Nanjing 31
Istanbul 30
Dublin 28
Indianapolis 27
Munich 25
Shanghai 25
Ho Chi Minh City 24
Santa Clara 24
Lauterbourg 23
Chicago 21
São Paulo 21
Hanoi 19
Jinan 18
London 18
San Francisco 18
Buffalo 17
North Bergen 17
Columbus 16
Dong Ket 16
Milan 16
Orem 16
Des Moines 15
Moscow 14
Central 13
Denver 13
Hangzhou 13
Dallas 12
Toronto 12
Turku 12
Montreal 11
Shenyang 11
Hebei 10
Jiaxing 10
Kunming 10
Rome 10
Chennai 9
Redondo Beach 9
Boston 8
Changsha 8
San Diego 8
Belo Horizonte 7
Brooklyn 7
Charlotte 7
Lanzhou 7
Nanchang 7
Phoenix 7
Atlanta 6
Miami 6
Monmouth Junction 6
Mooresville 6
Nuremberg 6
Stockholm 6
Tianjin 6
Tokyo 6
Baghdad 5
Brussels 5
Falkenstein 5
Jakarta 5
Leawood 5
Ningbo 5
Querétaro 5
Amsterdam 4
Biên Hòa 4
Cape Town 4
Cazzago San Martino 4
Frankfurt am Main 4
Guangzhou 4
Guarulhos 4
Hefei 4
Johannesburg 4
Manchester 4
Mumbai 4
Nardò 4
New Delhi 4
Norwalk 4
San José 4
Abuja 3
Totale 3.628
Nome #
Proc Natl Acad Sci U S A. 2013 Feb 19;110(8):2916-21. doi: 10.1073/pnas.1222577110. Epub 2013 Jan 28. Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma. Zhao S1, Choi M, Overton JD, Bellone S, Roque DM, Cocco E, Guzzo F, English DP, Varughese J, Gasparrini S, Bortolomai I, Buza N, Hui P, Abu-Khalaf M, Ravaggi A, Bignotti E, Bandiera E, Romani C, Todeschini P, Tassi R, Zanotti L, Carrara L, Pecorelli S, Silasi DA, Ratner E, Azodi M, Schwartz PE, Rutherford TJ, Stiegler AL, Mane S, Boggon TJ, Schlessinger J, Lifton RP, Santin AD 375
Identification of stably expressed reference small non-coding RNAs for microRNA quantification in high-grade serous ovarian carcinoma tissues 374
Evaluation of a novel human IgG1 anti-claudin3 antibody that specifically recognizes its aberrantly localized antigen in ovarian cancer cells and that is suitable for selective drug delivery 303
Tissue factor expression in ovarian cancer: implications for immunotherapy with hI-con1, a factor VII-IgGF(c) chimeric protein targeting tissue factor 245
Circulating miRNA landscape identifies miR-1246 as promising diagnostic biomarker in high-grade serous ovarian carcinoma: A validation across two independent cohorts 216
Secretoglobin expression in ovarian carcinoma: lipophilin B gene upregulation as an independent marker of better prognosis. 210
Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma 209
Trop-2 overexpression as an independent marker for poor overall survival in ovarian carcinoma patients. 200
HER2/neu as a potential target for immunotherapy in gynecologic carcinosarcomas 198
Identification of optimal reference genes for gene expression normalization in a wide cohort of endometrioid endometrial carcinoma tissues. 195
Trop-2 protein overexpression is an independent marker for predicting disease recurrence in endometrioid endometrial carcinoma 188
Mammaglobin B is an independent prognostic marker in epithelial ovarian cancer and its expression is associated with reduced risk of disease recurrence 186
MAL gene overexpression as a marker of high-grade serous ovarian carcinoma stem-like cells that predicts chemoresistance and poor prognosis 185
High-grade, chemotherapy-resistant primary ovarian carcinoma cell lines overexpress human trophoblast cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized monoclonal anti-Trop-2 antibody 173
Uterine serous papillary carcinomas overexpress human trophoblast-cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized anti-Trop-2 monoclonal antibody 171
Expression of tissue factor in adenocarcinoma and squamous cell carcinoma of the uterine cervix: implications for immunotherapy with hI-con1, a factor VII-IgGFc chimeric protein targeting tissue factor 165
Eradication of chemotherapy-resistant CD44+ human ovarian cancer stem cells in mice by intraperitoneal administration of Clostridium perfringens enterotoxin. 161
Claudin 7 downregulation is predictive of distant metastasis in high-grade serous carcinoma patients 161
The claudin-low subtype of high-grade serous ovarian carcinoma exhibits stem cell features 160
EXPRESSION PATTERN AND MOLECULAR FUNCTION OF TRASCRIPTION FACTOR FOXM1 (FORKHEAD BOX PROTEIN M1) IN EPITHELIAL OVARIAN CANCER CLINICAL SPECIMENS AND CELL LINES 154
Low Expression of Claudin-7 as Potential Predictor of Distant Metastases in High-Grade Serous Ovarian Carcinoma Patients 153
Expression profiles of PRKG1, SDF2L1 and PPP1R12A are predictive and prognostic factors for therapy response and survival in high-grade serous ovarian cancer 151
Pre-treatment Serum HE4 Level as a Novel Independent Prognostic Biomarker for Uterine Cervical Carcinoma Patients 131
FXYD5 (Dysadherin) upregulation predicts shorter survival and reveals platinum resistance in high-grade serous ovarian cancer patients 127
Integrated mutational landscape analysis of uterine leiomyosarcomas 125
Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors 114
Correction for Li et al., Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors 105
Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapy 99
Identification of optimal reference RNAs to normalize miRNA expression data by qRT-PCR in formalin-fixed, paraffin-embedded lymph node tissue 79
Totale 5.313
Categoria #
all - tutte 22.824
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.824


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022181 0 0 0 4 1 13 21 12 10 44 27 49
2022/2023292 48 15 13 13 25 53 5 31 53 2 17 17
2023/2024386 21 12 42 23 20 96 20 26 64 22 9 31
2024/2025556 6 12 6 83 37 69 29 22 55 36 128 73
2025/20261.480 155 134 98 248 182 112 246 43 76 112 54 20
2026/2027358 48 54 80 176 0 0 0 0 0 0 0 0
Totale 5.313